Normal view MARC view ISBD view

Activated macrophages distinguish undifferentiated-tumorigenic from differentiated-nontumorigenic murine erythroleukemia cells. [electronic resource]

By:

Pak, C C

Contributor(s):

Fidler, I J

Producer: 19891205Description: 49-55 p. digitalISSN:

0301-4681

Subject(s):

Online resources:

Available from publisher's website

In: Differentiation; research in biological diversity vol. 41

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.

There are no comments on this title.

to post a comment.

Back to results

1 Antitumor activity of cis-dichlorodiammineplatinum(II).
by Wolpert-DeFilippes, M K
2 Nude mouse models as predictors of chemotherapy in man: thymidine and pyrimidines.
by Goldin, A
3 Binding of maytansine to tubulin: competition with other mitotic inhibitors.
by Lin, C M
4 Stathmokinetic and therapeutic effects of maytansine in mice bearing P388 and L1210 leukemias.
by Johnson, R K
5 Binding of maytansine to rat brain tubulin.
by Mandelbaum-Shavit, F
6 Quantitative structure--activity correlations of rifamycins as inhibitors of viral RNA-directed DNA polymerase and mammalian alpha and beta DNA polymerases.
by Wu, R S
7 Potentials and drawbacks of the human tumor stem cell assay.
by Shoemaker, R H
8 Binding of maytansinoids to tubulin.
by York, J
9 Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
by Voytek, P
10 Initial studies on maytansine-induced metaphase arrest in L1210 murine leukemia cells.
by Wolpert-DeFilippes, M K
11 Initial studies on the cytotoxic action of maytansine, a novel ansa macrolide.
by Wolpert-Defilippes, M K
12 Synthesis, physical properties, and antitumor activity of tetraplatin and related tetrachloroplatinum(IV) stereoisomers of 1,2-diaminocyclohexane.
by Anderson, W K
13 Therapeutic and pharmacological studies of tetrachloro(d,l-trans)1,2-diaminocyclohexane platinum (IV) (tetraplatin), a new platinum analogue.
by Rahman, A
14 Reaction products of a new anti-cancer agent, Pt(IV)(cyclohexyldiamine)Cl4, with guanosine and 9-methylguanine: first crystal structures of Pt(cyclohexyldiamine) complexes with a nucleobase and a nucleoside.
by Choi, H K
15 Use of the KB cell line for in vitro cytotoxicity assays.
by Shoemaker, R H
16 A strategy for the development of two clinically active cisplatin analogs: CBDCA and CHIP.
by Foster, B J
17 Pleiotropic resistance and drug development.
by Shoemaker, R
18 Hexamethylene bisacetamide: a polar-planar compound entering clinical trials as a differentiating agent.
by Chun, H G
19 Application of a human tumor colony-forming assay to new drug screening.
by Shoemaker, R H